China SXT Pharmaceuticals, Inc. (SXTC)
USD 0.34
(-1.79%)
USD 0.34
(-1.79%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.92 Million | -80.75 Thousand | 268.29 Thousand | -1.31 Million | 934.24 Thousand | 239.19 Thousand |
| Net Income | -3.09 Million | -5.93 Million | -5.73 Million | -2.74 Million | -10.28 Million | 1.53 Million |
| Depreciation & Amortization | 203.24 Thousand | 250.16 Thousand | 320 Thousand | 345.41 Thousand | 331.83 Thousand | 180.91 Thousand |
| Deferred income taxes | - | 3.22 Million | 328.14 Thousand | -192.68 Thousand | -101.72 Thousand | -7723.00 |
| Stock-based compensation | 352.1 Thousand | 554.57 Thousand | 2.33 Million | - | - | - |
| Change in working capital | -381.55 Thousand | 1.41 Million | 1.9 Million | -1.6 Million | 1.94 Million | -1.54 Million |
| Other non-cash items | 2.29 Million | 408.68 Thousand | 1.11 Million | 1.61 Million | 3.35 Million | 66.88 Thousand |
| Investing Cash Flow | 26.42 Thousand | -12.3 Thousand | -46.9 Thousand | -5.8 Million | -5.49 Million | -610.08 Thousand |
| Investments in PPE | -7063.00 | -70.68 Thousand | -62.49 Thousand | -93.04 Thousand | -406.65 Thousand | -610.08 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -8.84 Million | -3.59 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 33.48 Thousand | 58.38 Thousand | 15.58 Thousand | 3.13 Million | -1.5 Million | -11.27 Thousand |
| Financing Cash Flow | -2.62 Million | 2.94 Million | 1.59 Million | 12.4 Million | 3.02 Million | 9.04 Million |
| Debt repayment | -1.3 Million | -26.1 Thousand | -33.05 Thousand | -124.94 Thousand | -1.19 Million | -2.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 6.49 Million |
| Common Stock Issuance | - | 2.19 Million | 3.11 Million | - | - | 6.49 Million |
| Other Financing Activities | -3.93 Million | 772.88 Thousand | -1.48 Million | 12.53 Million | 4.22 Million | 826.83 Thousand |
| Accounts receivables | -321.42 Thousand | 912.94 Thousand | 831.47 Thousand | -519.24 Thousand | 104 Thousand | -1.81 Million |
| Accounts payables | -29.25 Thousand | 9700.00 | -22.79 Thousand | -619.53 Thousand | 302.26 Thousand | -567.31 Thousand |
| Inventory | -190.29 Thousand | 408.95 Thousand | -180.79 Thousand | 38.62 Thousand | 39.7 Thousand | 177.63 Thousand |
| Other working capital | 159.4 Thousand | 83.91 Thousand | 1.27 Million | -506.07 Thousand | 1.5 Million | 660.62 Thousand |
| Cash at beginning of period | 17.36 Million | 15.56 Million | 13.35 Million | 7.28 Million | 9.29 Million | 657.76 Thousand |
| Cash at end of period | 12.07 Million | 17.36 Million | 15.56 Million | 13.35 Million | 7.28 Million | 9.29 Million |
| Capital Expenditure | -7063.00 | -70.68 Thousand | -62.49 Thousand | -93.04 Thousand | -406.65 Thousand | -610.08 Thousand |
| Effect of forex changes on cash | -765.23 Thousand | -1.04 Million | 394.12 Thousand | 784.53 Thousand | -466.81 Thousand | -37.02 Thousand |
| Net cash flow / Change in cash | -5.29 Million | 1.79 Million | 2.21 Million | 6.07 Million | -2 Million | 8.63 Million |
| Free Cash Flow | -1.93 Million | -151.44 Thousand | 205.8 Thousand | -1.4 Million | 527.58 Thousand | -370.89 Thousand |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.29 Million | -3.09 Million | 3.29 Million | -4.84 Million | -4.84 Million | -5.93 Million |
| Depreciation & Amortization | 90.28 Thousand | 203.24 Thousand | 90.28 Thousand | 157.72 Thousand | 51.37 Thousand | 250.16 Thousand |
| Deferred income taxes | - | - | - | - | - | 3.22 Million |
| Stock-based compensation | 176.05 Thousand | 352.1 Thousand | 176.05 Thousand | - | - | 554.57 Thousand |
| Change in working capital | -325.96 Thousand | -381.55 Thousand | -325.96 Thousand | 149.03 Thousand | 149.03 Thousand | 1.41 Million |
| Other non-cash items | -3.91 Million | 2.29 Million | -3.91 Million | 4.25 Million | 4.35 Million | 408.68 Thousand |
| Investing Cash Flow | 3392.00 | 26.42 Thousand | 3392.00 | 9820.00 | 9820.00 | -12.3 Thousand |
| Investments in PPE | -3532.00 | -7063.00 | -3532.00 | - | - | -70.68 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6924.00 | 33.48 Thousand | 6924.00 | 9820.00 | 9820.00 | 58.38 Thousand |
| Financing Cash Flow | 918.65 Thousand | -2.62 Million | 918.65 Thousand | -2.23 Million | -2.23 Million | 2.94 Million |
| Debt repayment | - | -1.3 Million | - | -120.37 Thousand | - | -26.1 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 2.19 Million |
| Other Financing Activities | 918.65 Thousand | -3.93 Million | 918.65 Thousand | -2.23 Million | -2.23 Million | 772.88 Thousand |
| Accounts receivables | -124.22 Thousand | -321.42 Thousand | -124.22 Thousand | -36.48 Thousand | -36.48 Thousand | 912.94 Thousand |
| Accounts payables | - | -29.25 Thousand | - | 19.35 Thousand | - | 9700.00 |
| Inventory | -75.86 Thousand | -190.29 Thousand | -75.86 Thousand | -19.27 Thousand | -19.27 Thousand | 408.95 Thousand |
| Other working capital | -125.87 Thousand | 159.4 Thousand | -125.87 Thousand | 204.79 Thousand | 204.79 Thousand | 83.91 Thousand |
| Cash at beginning of period | - | 17.36 Million | - | 17.36 Million | - | 15.56 Million |
| Cash at end of period | 306.08 Thousand | 12.07 Million | 306.08 Thousand | 11.46 Million | -2.95 Million | 17.36 Million |
| Capital Expenditure | -3532.00 | -7063.00 | -3532.00 | - | - | -70.68 Thousand |
| Effect of forex changes on cash | 58.28 Thousand | -765.23 Thousand | 58.28 Thousand | -440.89 Thousand | -440.89 Thousand | -1.04 Million |
| Net cash flow / Change in cash | 306.08 Thousand | -5.29 Million | 306.08 Thousand | -5.9 Million | -2.95 Million | 1.79 Million |
| Free Cash Flow | -677.77 Thousand | -1.93 Million | -677.77 Thousand | -289.78 Thousand | -289.78 Thousand | -151.44 Thousand |
KUMBF
002352
8030
NVG
WFC
6050